Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs.
暂无分享,去创建一个
[1] P. Bruggen,et al. Tumor antigens recognized by T lymphocytes. , 1994, Annual review of immunology.
[2] A Sette,et al. The peptide-binding motif for the human transporter associated with antigen processing , 1995, The Journal of experimental medicine.
[3] M F del Guercio,et al. Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.
[4] M. Powell,et al. Vaccine Design , 1995, Pharmaceutical Biotechnology.
[5] R. Winchester,et al. Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection. , 1995, Human immunology.
[6] J. Howard. Supply and transport of peptides presented by class I MHC molecules. , 1995, Current opinion in immunology.
[7] R. Germain,et al. The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.
[8] D. Wiley,et al. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.
[9] F. Chisari,et al. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis , 1993, The Journal of experimental medicine.
[10] M. Aidoo,et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria , 1992, Nature.
[11] P. Parham,et al. Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes , 1995, Current Biology.
[12] A Sette,et al. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. , 1994, Journal of immunology.
[13] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[14] M F del Guercio,et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. , 1996, Human immunology.
[15] H. Grey,et al. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. , 1995, Molecular immunology.
[16] G Hermanson,et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. , 1995, Journal of immunology.
[17] R. Tosi,et al. HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A-locus allelic products. , 1994, Human immunology.
[18] A. Vitiello,et al. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. , 1995, The Journal of clinical investigation.
[19] D. Madden. The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.
[20] P. Stastny,et al. DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. , 1992, Human immunology.
[21] A Sette,et al. Definition of specific peptide motifs for four major HLA-A alleles. , 1994, Journal of immunology.
[22] E. Adams,et al. The Origins of HLA‐A,B,C Polymorphism , 1995, Immunological reviews.
[23] J. Trapani,et al. Molecular analysis of the serologically defined HLA-Aw19 antigens. A genetically distinct family of HLA-A antigens comprising A29, A31, A32, and Aw33, but probably not A30. , 1989, Journal of immunology.
[24] A. Vitiello,et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.